| 1 | | $172B | $321.33 | -0.09% | |
| 2 | | $168B | $473.73 | -0.6% | |
| 3 | | $166B | $29.27 | -1.35% | |
| 4 | | $137B | $359.73 | -0.44% | |
| 5 | | $129B | $498.73 | +2.36% | |
| 6 | | $127B | $86.42 | -0.67% | |
| 7 | | $115B | $89.79 | -0.22% | |
| 8 | Regeneron Pharmaceuticals | $110B | $998.23 | -0.97% | |
| 9 | | $109B | $87.36 | +0.7% | |
| 10 | | $108B | $53.18 | -0.36% | |
| 11 | | $105B | $406.48 | -0.67% | |
| 12 | | $86.5B | $191 | -1.77% | |
| 13 | | $74.5B | $135.68 | -0.49% | |
| 14 | | $69.5B | $240.33 | +0.04% | |
| 15 | | $66B | $508.72 | -0.43% | |
| 16 | | $46.2B | $235.64 | -0.39% | |
| 17 | | $41.5B | $90.82 | +0.67% | |
| 18 | | $41.2B | $68.47 | +0.25% | |
| 19 | | $38.1B | $296.75 | -1.26% | |
| 20 | | $37.9B | $460.01 | -0.84% | |
| 21 | | $35.2B | $239.59 | +0.52% | |
| 22 | | $27.9B | $69.55 | -0.5% | |
| 23 | | $27.6B | $189.55 | +0.29% | |
| 24 | | $27.3B | $111.93 | -0.55% | |
| 25 | | $22.5B | $212.39 | -4.4% | |
